Search Results

Scorpius Holdings, Inc reported that it received notice from the NYSE American of its determination to commence delisting proceedings of the Company’s common stock from the exchange pursuant to Section 1003 of the NYSE American Company Guide due to the low-selling price of the Company’s common stock.

Bio-Path Holdings, Inc. announced an upcoming oral presentation at the American Society of Clinical Oncology Annual Meeting, taking place May 31 - June 4, 2024 in Chicago, IL.

Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.

Scilex Holding Company announced it will be presenting a poster on ELYXYB® at the 66th Annual Scientific Meeting of the American Headache Society to be held in San Diego, CA on June 13-16, 2024.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in innovative technology designed to safeguard against electromagnetic radiation and enhance human well-being, issues this news release in order to clarify certain financial disclosure contained in its news release dated June 18, 2024 (the “June 18th Press Release”).

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American College of Cardiology (ACC.24) at the Georgia World Congress Center in Atlanta, GA, April 6 – 8, 2024.

Bio-Path Holdings, Inc. presented interim results from the Company’s Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia in an oral presentation at the American Society of Clinical Oncology Annual Meeting, on June 1, 2024 in Chicago, IL.

With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in innovative technology designed to safeguard against electromagnetic radiation and enhance human well-being, is pleased to share a corporate update highlighting the Company’s strong growth and promising future outlook. Despite recent stock price fluctuations, Aires’ fundamentals remain solid, and the Company continues to execute its strategic plan with precision and vigor.